Literature DB >> 2883260

Evidence for somatostatin-containing fibers projecting from the pallidal complex to the striatum of the rat.

R Widmann, N Mensdorff-Pouilly, K Pfaller, G Sperk.   

Abstract

The origin of afferent somatostatin-containing fibers terminating in medial and ventral parts of the striatum has been investigated by performing various neurochemical and surgical lesions in the rat. Lesions of the anterior hypothalamus, amygdala, and the hippocampal commissure as well as lesions with 6-hydroxydopamine and 5,7-dihydroxytryptamine failed to decrease striatal somatostatin levels. However, thermal coagulation of the globus pallidus or knife-cut lesions performed ventrally to the striatum resulted in significant decreases in striatal somatostatin content. Analysis of the topographical distribution of somatostatin within the striatum after thermal lesions of the globus pallidus as well as after kainic acid-induced seizures revealed a preferential loss of the peptide in medial and ventral portions of the striatum, the site of terminating afferent somatostatin nerve fibers. The data suggest that the striatal afferent somatostatin-containing neurons may originate in the area of the globus pallidus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2883260     DOI: 10.1111/j.1471-4159.1987.tb05748.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  2 in total

1.  Presence of somatostatin or neurotensin in lateral septal dopaminergic axon terminals of distinct hypothalamic and midbrain origins: convergence on the somatospiny neurons.

Authors:  R L Jakab; C Leranth
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

2.  Somatostatin 1.1 contributes to the innate exploration of zebrafish larva.

Authors:  Feng B Quan; Laura Desban; Olivier Mirat; Maxime Kermarquer; Julian Roussel; Fanny Koëth; Hugo Marnas; Lydia Djenoune; François-Xavier Lejeune; Hervé Tostivint; Claire Wyart
Journal:  Sci Rep       Date:  2020-09-17       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.